A Study of ICP-022 in Patients With Systemic Lupus Erythematosus (SLE)

  • days left to enroll
  • participants needed
  • sponsor
    Beijing InnoCare Pharma Tech Co., Ltd.
Updated on 31 May 2021
antinuclear antibody


The purpose of the study is to assess the Safety, Tolerability, PK/PD and preliminary Efficacy of ICP-022 in Subjects with Systemic Lupus Erythematosus (SLE)

Condition Autoimmune disease, CONNECTIVE TISSUE DISEASE, Systemic Lupus Erythematosus, Autoimmune Disease, SYSTEMIC LUPUS ERYTHEMATOSUS, Connective Tissue Diseases, Dermatomyositis (Connective Tissue Disease)
Treatment placebos, ICP-022
Clinical Study IdentifierNCT04305197
SponsorBeijing InnoCare Pharma Tech Co., Ltd.
Last Modified on31 May 2021


Yes No Not Sure

Inclusion Criteria

Male or female subjects aged 18 to 75
diagnosis of with SLE at least 6 months at screening visit
Is receiving standard treatment for SLE and has been receiving treatment for at least 3 months
At least one SLE activity manifestation (as assessed by SLEDAE-2K)

Exclusion Criteria

Failure to comply with the requirements of the programme
A female or male partner who is pregnant or breastfeeding or who plans to become pregnant during the study period
Previously treated with a BTK inhibitor
Neuropsychiatric lupus (NPSLE)
Has other autoimmune diseases other than SLE
Note: Other protocol defined Inclusion/Exclusion criteria may apply
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact



Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note